38 results on '"Hogan, William J."'
Search Results
2. Characteristics and prognosis of mutated STAG2 myeloid neoplasms.
3. Treatment with anti-spike monoclonal antibodies in allogeneic HCT and CAR T-cell recipients with mild to moderate COVID-19: The Mayo Clinic experience.
4. Chemotherapy-based stem cell mobilization in multiple myeloma patients treated with novel agents: The Mayo Clinic experience.
5. Adult Philadelphia-like B-cell acute lymphoblastic leukemia: Characteristics, outcomes, and role of allogeneic hematopoietic cell transplantation in comparison to Philadelphia-positive and Philadelphia-negative acute lymphoblastic leukemia.
6. Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
7. Prognostic role of beta-2 microglobulin in patients with light chain amyloidosis treated with autologous stem cell transplantation.
8. A population-based study of chronic neutrophilic leukemia in the United States: 2004 to 2015.
9. Depth of response prior to autologous stem cell transplantation to predict survival in light chain amyloidosis.
10. Outcomes of stem cell transplant in patients with Richter transformation.
11. Discrepancy of blast percentage between the bone marrow aspirate and biopsy and its impact on survival outcomes in patients with myelodysplastic syndromes excess blast (MDS-EB).
12. Outcomes of patients with light chain amyloidosis who had autologous stem cell transplantation with three or more organs involved.
13. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome per 2017 WHO guideline compared to de novo MDS.
14. The impact of clonal size on the revised international prognostic scoring system (R-IPSS) in myelodysplastic syndromes (MDS) with a single cytogenetic abnormality.
15. Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
16. Clinical significance of HFE gene mutations in patients with refractory anemia with ring sideroblasts (RARS).
17. Prognostic impact of kinetics of circulating plasma cells before and after induction therapy in newly diagnosed multiple myeloma patients undergoing early transplantation.
18. Effect of echocardiogram prior to induction therapy for acute myeloid leukemia on detection of cardiac dysfunction and treatment modifications.
19. Interaction between ring sideroblasts and treatment with hypomethylating agents (HMA) in patients with refractory anemia with ring sideroblasts.
20. Prognostic and therapeutic impact of cytogenetic abnormalities in patients with myelodysplastic/myeloproliferative neoplasms, unclassifiable.
21. In-hospital outcomes of acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant (HCT).
22. Presence of interstitial lung diseases (ILD) in patients diagnosed with myelodysplastic syndromes (MDS): Mayo Clinic experience.
23. The impact of novel induction regimens on transplant outcome in newly diagnosed multiple myeloma after controlling for high-risk FISH cytogenetics.
24. Acute leukemia in pregnancy: A single institution experience.
25. Case series of hypomethylating agents (HMA) effect on myelodysplastic/myeloproliferative neoplasm unclassified (MDS/MPN-U): Mayo Clinic experience.
26. Infused autograft lymphocyte to monocyte ratio and survival in T-cell lymphomas post-autologous peripheral blood hematopoietic stem cell transplantation.
27. Phase III trial of stem cell transplantation compared to melphalan and dexamethasone in the treatment of immunoglobulin light chain amyloidosis (AL).
28. The prognostic impact of combined NPM1+/FLT3- mutational status in newly diagnosed acute myeloid leukemia (AML) patients with intermediate risk cytogenetics according to age and treatment modality.
29. Higher CD3 cell counts in apheresis collection in relation to superior survival in patients with multiple myeloma.
30. Effect of grade (G) 3 fibrosis on clinical outcome of patients (Pts) with myelodysplastic syndromes (MDS): Mayo Clinic Experience.
31. Effect of prior hypomethylating agent (HMA) use on clinical outcome of patients (Pts) with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndrome (MDS) when treated with standard induction chemotherapy (7+3).
32. Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
33. Correlation of KIT expression with higher FLT3 mutations and impact on clinical outcome in patients newly diagnosed with acute myeloid leukemia (AML).
34. Effect of obesity on overall survival in patients diagnosed with chronic myelomonocytic leukemia (CMML).
35. Body mass index impact on acute myeloid leukemia (AML) outcomes.
36. Day 100 peripheral blood absolute monocyte/lymphocyte count prognostic score and survival in diffuse large B-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation.
37. Second autologous stem cell transplantation as a strategy for management of relapsed multiple myeloma.
38. CDKN2A-deletion to predict relapse in adult B-cell acute lymphoblastic leukemia (B-ALL).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.